Sacrosidase
From Wikipedia, the free encyclopedia
|
Sacrosidase
|
|
| Systematic (IUPAC) name | |
| ? | |
| Identifiers | |
| CAS number | ? |
| ATC code | A16 |
| PubChem | ? |
| Chemical data | |
| Formula | ? |
| Mol. mass | ? |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Sacrosidase (trade name Sucraid) is a medication used to replace sucrase in people lacking this enzyme.[1] It is available as an oral solution.
[edit] References
- ^ Treem WR, McAdams L, Stanford L, Kastoff G, Justinich C, Hyams J (1999). "Sacrosidase therapy for congenital sucrase-isomaltase deficiency". J. Pediatr. Gastroenterol. Nutr. 28 (2): 137–42. PMID 9932843.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
|
|||||||||||
